Entera Bio Ltd

Penny Stocks Biotech Stocks Healthcare Stocks

$1.77

+0.12 (+7.27%)

As of Jun 30, 10:41 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +2,361.6% upside

Low Target $34.30

Average Target $43.57

High Target $49.66

Current Price $1.77

Current
$1.77

Target
$43.57

$34.30 $43.57 avg $49.66

Scenario Analysis

Bear Case

$34.30

1,837.9%

Low target

Base Case

$43.57

+2,361.6%

Avg target

Bull Case

$49.66

+2,705.6%

High target

Risk/Reward

1.5x

Balanced

Price in Context

52-Week High

$3.22

-45.0% from high

52-Week Low

$0.91

+94.5% from low

Target vs 52W High

$43.57

+1,253.1% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%